| 000 | 01640 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515010053.0 | ||
| 264 | 0 | _c20060206 | |
| 008 | 200602s 0 0 eng d | ||
| 022 | _a1540-1405 | ||
| 024 | 7 |
_a10.6004/jnccn.2005.0049 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCampos, Susana M | |
| 245 | 0 | 0 |
_aBenefits associated with an early hemoglobin response to epoetin alfa therapy in the treatment of chemotherapy-related anemia. _h[electronic resource] |
| 260 |
_bJournal of the National Comprehensive Cancer Network : JNCCN _cNov 2005 |
||
| 300 |
_a807-16 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnemia _xchemically induced |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aBlood Transfusion |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aEpoetin Alfa |
| 650 | 0 | 4 |
_aErythropoietin _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematinics _xtherapeutic use |
| 650 | 0 | 4 |
_aHemoglobins _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDuh, Mei Sheng | |
| 700 | 1 | _aLefebvre, Patrick | |
| 700 | 1 | _aRosberg, James | |
| 773 | 0 |
_tJournal of the National Comprehensive Cancer Network : JNCCN _gvol. 3 _gno. 6 _gp. 807-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.6004/jnccn.2005.0049 _zAvailable from publisher's website |
| 999 |
_c15939230 _d15939230 |
||